These findings agree with Howell et al. (2013) and Hartman et al. (2009) who claimed that chronic activation of mTOR induces insulin resistance through inhibiting the phosphorylation of insulin receptor substrate-1 (IRS1) by mTORC1, and enhancing its proteosomal degradation by mTORC2. The gene discussed is IRS1; the disease is Insulin resistance.